As such, the antitumor immune response intensity and persistence caused by PD-1 blockers, tumor vaccines, or adoptive cell transfer64 may be more dependent on the number and function of TCF1+ precursor exhausted cells at the lesion site rather than terminally exhausted T cells. This evidence concerns the gene PDCD1 and neoplasm.